DISPOSITION OF ORAL METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND ITS RELATION TO 6-MERCAPTOPURINE PHARMACOKINETICS

被引：0
|
作者：
KOREN, G
SOLH, H
KLEIN, J
SOLDIN, SJ
GREENBERG, M
机构：
[1] UNIV TORONTO,HOSP SICK CHILDREN,DIV HEMATOL ONCOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA
[3] UNIV TORONTO,HOSP SICK CHILDREN,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA
[4] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
[5] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PHARMACOL,TORONTO M5G 1X8,ONTARIO,CANADA
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1989年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：450 / 454
页数：5
相关论文
共 50 条
  • [31] CHILDHOOD LYMPHOBLASTIC-LEUKEMIA - SEX DIFFERENCE IN 6-MERCAPTOPURINE UTILIZATION
    LILLEYMAN, JS
    LENNARD, L
    REES, CA
    MORGAN, G
    MADDOCKS, JL
    BRITISH JOURNAL OF CANCER, 1984, 49 (06) : 703 - 707
  • [32] Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine
    Norbert Erb
    Dörthe O. Harms
    Gritta Janka-Schaub
    Cancer Chemotherapy and Pharmacology, 1998, 42 : 266 - 272
  • [33] Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine
    Erb, N
    Harms, DO
    Janka-Schaub, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (04) : 266 - 272
  • [34] COMPLEX EVALUATION OF PHARMACOKINETICS AND METABOLISM OF METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    BORSI, JD
    SAGEN, E
    ROMSLO, I
    MOE, PJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (06): : 331 - 331
  • [35] Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia
    Nielsen, Stine Nygaard
    Grell, Kathrine
    Nersting, Jacob
    Frandsen, Thomas Leth
    Hjalgrim, Lisa Lyngsie
    Schmiegelow, Kjeld
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (05) : 983 - 994
  • [36] Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia
    Stine Nygaard Nielsen
    Kathrine Grell
    Jacob Nersting
    Thomas Leth Frandsen
    Lisa Lyngsie Hjalgrim
    Kjeld Schmiegelow
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 983 - 994
  • [37] The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia
    de Beaumais, T. Adam
    Dervieux, T.
    Fakhoury, M.
    Medard, Y.
    Azougagh, S.
    Zhang, D.
    Yakouben, K.
    Jacqz-Aigrain, E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 653 - 658
  • [38] The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia
    T. Adam de Beaumais
    T. Dervieux
    M. Fakhoury
    Y. Medard
    S. Azougagh
    D. Zhang
    K. Yakouben
    E. Jacqz-Aigrain
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 653 - 658
  • [39] VINCRISTINE DISPOSITION IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    DEGRAAF, SSN
    BLOEMHOF, H
    VENDRIG, DEMM
    UGES, DRA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04): : 235 - 240
  • [40] 6-Mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia
    K Schmiegelow
    U Bretton-Meyer
    Leukemia, 2001, 15 : 74 - 79
12345